C-H Lin1, R-M Wu, H-Y Chang, Y-T Chiang, H-H Lin. 1. Department of Neurology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Abstract
BACKGROUND AND PURPOSE: Painful sensations are recently reported to be a non-motor feature of Parkinson's disease (PD). The non-steroidal anti-inflammatory drug ibuprofen is a common painkiller and was reported to be associated with a decreased risk of PD. The aim of the present study was to examine the relationship amongst preceding pain symptoms, use of ibuprofen and risk of PD in a nationwide population-based cohort. METHODS: The data of participants who were free of PD at baseline were obtained from two large National Health Interview Surveys (NHIS) in Taiwan, conducted in 2001 and 2005. The information regarding pain status included severity and location of pain. Information regarding pain status, use of ibuprofen, comorbidity of depression and PD-associated risk/protective behaviors was adjusted using proportional hazards models. RESULTS: Amongst 33 388 participants, 32 cases of incident PD were identified after a mean follow-up of 3 years. After adjusting for the use of ibuprofen and other PD risk factors, subjects with preceding pain symptoms had a higher incidence of PD than those without pain at baseline, and the hazard ratio was 1.79 (95% CI: 0.71-4.51, P = 0.21) for mild pain and 2.88 (95% CI: 1.05-7.86, P = 0.04) for moderate or severe pain. The PD risk increased by 34% with each additional increment in pain score [hazard ratio = 1.34 (1.03-1.75), P = 0.03], showing a dose-response relationship. CONCLUSIONS: These findings support the hypothesis that pain is associated with PD in the pre-motor stage of the disease. Further research is needed to clarify the role of sensory system involvement in the pre-motor phase of PD.
BACKGROUND AND PURPOSE:Painful sensations are recently reported to be a non-motor feature of Parkinson's disease (PD). The non-steroidal anti-inflammatory drug ibuprofen is a common painkiller and was reported to be associated with a decreased risk of PD. The aim of the present study was to examine the relationship amongst preceding pain symptoms, use of ibuprofen and risk of PD in a nationwide population-based cohort. METHODS: The data of participants who were free of PD at baseline were obtained from two large National Health Interview Surveys (NHIS) in Taiwan, conducted in 2001 and 2005. The information regarding pain status included severity and location of pain. Information regarding pain status, use of ibuprofen, comorbidity of depression and PD-associated risk/protective behaviors was adjusted using proportional hazards models. RESULTS: Amongst 33 388 participants, 32 cases of incident PD were identified after a mean follow-up of 3 years. After adjusting for the use of ibuprofen and other PD risk factors, subjects with preceding pain symptoms had a higher incidence of PD than those without pain at baseline, and the hazard ratio was 1.79 (95% CI: 0.71-4.51, P = 0.21) for mild pain and 2.88 (95% CI: 1.05-7.86, P = 0.04) for moderate or severe pain. The PD risk increased by 34% with each additional increment in pain score [hazard ratio = 1.34 (1.03-1.75), P = 0.03], showing a dose-response relationship. CONCLUSIONS: These findings support the hypothesis that pain is associated with PD in the pre-motor stage of the disease. Further research is needed to clarify the role of sensory system involvement in the pre-motor phase of PD.
Authors: Evangelia Boura; Maria Stamelou; David Vadasz; Vincent Ries; Marcus M Unger; Georg Kägi; Wolfgang H Oertel; Jens C Möller; Veit Mylius Journal: J Neurol Date: 2017-01-24 Impact factor: 4.849
Authors: Sebastian Heinzel; Benjamin Roeben; Yoav Ben-Shlomo; Stefanie Lerche; Guido Alves; Paolo Barone; Stefanie Behnke; Henk W Berendse; Bastiaan R Bloem; David Burn; Richard Dodel; Donald G Grosset; Michele Hu; Meike Kasten; Rejko Krüger; Marcello Moccia; Brit Mollenhauer; Wolfgang Oertel; Ulrike Suenkel; Uwe Walter; Karin Wirdefeldt; Inga Liepelt-Scarfone; Walter Maetzler; Daniela Berg Journal: Front Aging Neurosci Date: 2016-06-22 Impact factor: 5.750
Authors: Katherine C Hughes; Xiang Gao; Samantha Molsberry; Linda Valeri; Michael A Schwarzschild; Alberto Ascherio Journal: Neurology Date: 2019-11-12 Impact factor: 9.910
Authors: Veit Mylius; Daniel Ciampi de Andrade; Rubens Gisbert Cury; Michael Teepker; Uwe Ehrt; Karla Maria Eggert; Serafin Beer; Jürg Kesselring; Maria Stamelou; Wolfgang H Oertel; Jens Carsten Möller; Jean-Pascal Lefaucheur Journal: Mov Disord Clin Pract Date: 2015-08-09